慢性閉塞性肺疾患の患者に2型糖尿病を発症させるための予測モデルの構築と検証
Xi Kang1, Tianye Li2, Qinyang Chen1
1School of Public Health, Lan Zhou University, Lanzhou, China.
Frontiers in endocrinology
|September 2, 2025
まとめ
この研究では,慢性閉塞性肺疾患 (COPD) の患者における2型糖尿病 (T2DM) の主要な要因を特定し,視覚化された予測モデルを開発した. このモデルは,COPD集団における標的型予防戦略の早期のT2DMリスク識別に役立ちます.
科学分野:
- 肺医学
- 内分泌学
- バイオ統計学
背景:
- 2型糖尿病 (T2DM) は,慢性閉塞性肺疾患 (COPD) の患者における頻繁な併発症である.
- この併発症は,COPD患者の再入院と死亡のリスクを大幅に高めます.
- COPDの要因を特定し,T2DMを予測することは,患者の管理に極めて重要です.
研究 の 目的:
- COPD患者のT2DMに影響を与える要因を特定する.
- COPDにおけるT2DMの可視化予測モデルを構築する.
- 早期にリスクを特定し,標的を絞って予防する.
主な方法:
- 1773人のCOPD患者の医療記録を遡及的に分析した (2020-2023年).
- LASSO,ピアソン相関,および多線性診断を用いた変数選択.
- 後方段階的選択 (AIC) とノモグラムによるモデルの構築,ROC曲線,校正プロット,H-Lテスト,DCA,k-foldクロス検証で検証された.
主要な成果:
- COPD患者のT2DMの罹患率は27. 13%でした.
- PCO2,中性粒子の数,CRP,ESR,ビリルビン,トリグリセリド,BMIの7つの独立予測要因が特定されました.
- 視覚化されたモデルは,良好な予測性能 (C指数=0. 78,AUC=0. 79- 0. 80) と臨床有用性を示した.
結論:
- COPD患者のT2DMリスクの可視化予測モデルが開発され,内部で検証された.
- このツールは リスクの高い個人を早期に特定するのに役立ちます
- 汎用性を確認するために外部検証が推奨されます.
関連する概念動画
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Carbohydrate Metabolism
11.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.7K
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K


